Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

Recruiting

Phase 1

Dexamethasone Implant for Retinal Detachment in Uveal MelanomaDexamethasone Implant for Retinal Detachment in Uveal Melanoma

Sponsor:

Ivana K. Kim

Code:

NCT04082962

Conditions

Exudative Retinal Detachment and Uveal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dexamethasone intravitreal implant

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-04. This information was provided to ClinicalTrials.gov by Ivana K. Kim on 2021-07-29.